Month: June 2018

June 30, 2018June 30, 2018

The US Government Has Charged Hundreds of People With Health Care Fraud and Aiding the Opioid Crisis

Opioids News

Publication date: Jun 30, 2018 Federal prosecutors have charged hundreds of people with allegedly defrauding the US government’s health care system out of a combined $2 billion. And many of ... Read more

June 30, 2018June 30, 2018

DEA, DOJ, Making Moves to Contain Opioid Supply Chain

Opioids News

Publication date: Jun 30, 2018 At a time when the Trump Administration is attempting to make inroads against the opioid crisis, the DEA and Justice Department are taking higher profile ... Read more

June 30, 2018June 30, 2018

Updated ‘My MS Manager’ App Now Offers More Features, MSAA Announces

Multiple Sclerosis News

Publication date: Jun 29, 2018 The Multiple Sclerosis Association of America (MSAA) recently launched a new version of the My MS Manager, a mobile app designed to provide convenient services ... Read more

June 30, 2018June 30, 2018

Sativex Relieves Pain in MS Patients, Italian Study Confirms

Multiple Sclerosis News

Publication date: Jun 29, 2018 Researchers confirmed that Sativex spray is beneficial in alleviating pain in patients with multiple sclerosis (MS), and also improved their pain sensitivity to cold temperatures. ... Read more

June 30, 2018June 30, 2018

Epigenetic Regulation of HLA Region Increases Risk of Multiple Sclerosis

Multiple Sclerosis News

Publication date: Jun 30, 2018 A new study conducted at the Karolinska Institutet in Sweden has discovered an epigenetic regulatory mechanism of the human leukocyte antigen (HLA) region of the ... Read more

June 30, 2018June 30, 2018

Pembrolizumab: Monotherapy Versus Combination Therapy

Melanoma Media

Publication date: Jun 29, 2018 Mark A. Socinski, MD; Karen Kelly, MD; Corey J. Langer, MD, FACP; and Benjamin P. Levy, MD, discuss practical implications for treating metastatic non-small cell ... Read more

June 30, 2018June 30, 2018

FDA Approval in Melanoma, Priority Reviews in AML and WM, NDAs in Melanoma and SCLC, and More

Melanoma Media

Publication date: Jun 29, 2018 Gina Columbus reports on an FDA approval in melanoma, priority review designations in acute myeloid leukemia and Waldenstrom macroglobulinemia, new drug applications accepted in melanoma ... Read more

June 30, 2018June 30, 2018

Experimental drug offers hope for advanced skin cancer patients

Melanoma Media

Publication date: Jun 29, 2018 Cemiplimab has the attention of the Food and Drug Administration, which could approve it for more widespread use as early as October.

June 30, 2018

Melanoma & nuclear medicine: new insights & advances

Melanoma News

Publication date: Jun 28, 2018 Request Username Can’t sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an ... Read more

June 30, 2018June 30, 2018

Otago researchers’ discovery unlocks secrets behind cancer drug resistance

Melanoma News

Publication date: Jun 28, 2018 (University of Otago) University of Otago research provides insights into an underlying mechanism that could explain why new cancer therapies to help treat metastatic melanoma ... Read more